Detalhe da pesquisa
1.
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
Ann Oncol
; 30(4): 582-588, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715153
2.
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).
Ann Oncol
; 29(8): 1853-1860, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982279
3.
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.
Ann Oncol
; 28(3): 583-589, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27998967
4.
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.
Ann Oncol
; 26(12): 2375-91, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26371282
5.
Poultry enteric inflammation model with dextran sodium sulfate mediated chemical induction and feed restriction in broilers.
Poult Sci
; 94(6): 1220-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25877409
6.
Immune modulation for cancer therapy.
Br J Cancer
; 111(12): 2214-9, 2014 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25211661
7.
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies.
Ann Oncol
; 25(11): 2277-2284, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25210016
8.
Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials.
Ann Oncol
; 24(8): 2174-80, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23666915
9.
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.
Ann Oncol
; 27(7): 1362, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27072927
10.
Coupling and uncoupling of tumor immunity and autoimmunity.
J Exp Med
; 190(11): 1717-22, 1999 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-10587362
11.
Phase II trial of neoadjuvant temozolomide in resectable melanoma patients.
Ann Oncol
; 21(8): 1718-1722, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20080829
12.
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.
Ann Oncol
; 21(8): 1712-1717, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20147741
13.
Tumor immunity and autoimmunity induced by immunization with homologous DNA.
J Clin Invest
; 102(6): 1258-64, 1998 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-9739060
14.
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor.
Eur J Cancer
; 60: 12-25, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27043866
15.
Activation of NF-kappa B may be necessary but is not sufficient for induction of H-2 antigens by TNF in J558L murine myeloma cells.
J Leukoc Biol
; 55(1): 7-12, 1994 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8283141
16.
Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.
Cancer Immun
; 1: 9, 2001 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-12747770
17.
Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.
Surgery
; 128(2): 273-80, 2000 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10923004
18.
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretion.
Urology
; 51(3): 489-91, 1998 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-9510360
19.
Vaccines and other adjuvant therapies for melanoma.
Hematol Oncol Clin North Am
; 12(4): 835-48, vii, 1998 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9759582
20.
Clinical results using biochemotherapy as a standard of care in advanced melanoma.
Melanoma Res
; 12(4): 381-7, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12170188